Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › AR › MALVERN › BAPTIST HEALTH

BAPTIST HEALTH

NPI: 1902868391 · MALVERN, AR 72104 · Rehabilitation Clinic/Center · NPI assigned 04/03/2006

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official WELLS, TROY controls 20+ related entities in our dataset. Read more

$2.68M
Total Medicaid Paid
143,082
Total Claims
116,202
Beneficiaries
123
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialWELLS, TROY (PRESIDENT)
NPI Enumeration Date04/03/2006

Related Entities

Other providers sharing the same authorized official: WELLS, TROY

ProviderCityStateTotal Paid
BAPTIST HEALTH REGIONAL HOSPITALS FORT SMITH AR $17.49M
BAPTIST HEALTH LITTLE ROCK AR $16.48M
BAPTIST HEALTH NORTH LITTLE ROCK AR $14.02M
BAPTIST HEALTH ARKADELPHIA AR $4.82M
CONWAY COMMUNITY SERVICES CONWAY AR $4.12M
BAPTIST HEALTH HEBER SPRINGS AR $3.69M
BAPTIST HEALTH HOSPITALS STUTTGART AR $2.97M
BAPTIST HEALTH LITTLE ROCK AR $2.93M
BAPTIST HEALTH REGIONAL HOSPITALS VAN BUREN AR $2.46M
BAPTIST HEALTH LITTLE ROCK AR $1.83M
BAPTIST HEALTH ARKADELPHIA AR $1.51M
BAPTIST HEALTH HOSPITALS STUTTGART AR $901K
BAPTIST HEALTH LITTLE ROCK AR $780K
BAPTIST HEALTH NORTH LITTLE ROCK AR $411K
BAPTIST HEALTH MONTICELLO AR $367K
BAPTIST HEALTH CONWAY AR $142K
BAPTIST HEALTH LITTLE ROCK AR $88K
BAPTIST HEALTH PRESCOTT AR $33K
BAPTIST HEALTH MALVERN AR $31K
BAPTIST HEALTH HEBER SPRINGS AR $22K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 22,164 $276K
2019 25,480 $358K
2020 17,629 $347K
2021 20,927 $404K
2022 24,459 $572K
2023 20,767 $471K
2024 11,656 $253K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 2,896 2,660 $342K
74177 Computed tomography, abdomen and pelvis; with contrast material 1,665 1,521 $269K
70450 Computed tomography, head or brain; without contrast material 2,648 2,352 $260K
80053 Comprehensive metabolic panel 10,653 8,954 $240K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 5,546 1,387 $240K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1,691 1,496 $164K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 10,904 9,009 $80K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1,516 1,275 $62K
74176 Computed tomography, abdomen and pelvis; without contrast material 732 668 $54K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 4,606 3,782 $54K
80048 Basic metabolic panel (calcium, ionized) 2,734 2,282 $49K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 419 407 $48K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 3,541 2,921 $44K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 2,111 1,732 $43K
71045 Radiologic examination, chest; single view 4,606 3,976 $40K
72125 Computed tomography, cervical spine; without contrast material 304 280 $38K
84484 4,100 3,056 $32K
83880 1,483 1,249 $32K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 739 689 $30K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2,668 2,382 $28K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 552 517 $25K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 2,013 1,822 $24K
87040 2,119 1,313 $23K
81025 2,315 2,080 $21K
82550 3,880 2,964 $21K
96361 Intravenous infusion, hydration; each additional hour 1,166 882 $19K
36415 Collection of venous blood by venipuncture 6,979 5,960 $19K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 554 409 $18K
87088 2,101 1,815 $17K
71046 Radiologic examination, chest; 2 views 912 815 $17K
85027 2,683 2,305 $16K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 5,084 4,568 $16K
83605 1,692 1,363 $15K
83690 1,963 1,767 $15K
80305 1,014 928 $15K
81001 4,742 4,149 $14K
80061 Lipid panel 1,071 959 $14K
96375 Therapeutic injection; each additional sequential IV push 1,529 1,320 $13K
73560 494 443 $12K
87631 135 123 $12K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 60 51 $11K
82150 1,165 1,066 $9K
82077 451 404 $9K
87077 987 857 $9K
80050 General health panel 189 164 $7K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 190 156 $7K
81003 2,789 2,496 $7K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 1,299 1,070 $7K
83735 1,227 985 $7K
87086 Culture, bacterial; quantitative colony count, urine 848 732 $6K
84443 Thyroid stimulating hormone (TSH) 392 352 $6K
77067 Screening mammography, bilateral, including computer-aided detection 114 112 $6K
J0696 Injection, ceftriaxone sodium, per 250 mg 1,580 1,290 $5K
99283 Emergency department visit for the evaluation and management, moderate severity 861 779 $5K
J2405 Injection, ondansetron hydrochloride, per 1 mg 2,460 2,071 $5K
J1885 Injection, ketorolac tromethamine, per 15 mg 2,822 2,425 $5K
87186 921 801 $5K
82962 883 410 $5K
99284 Emergency department visit for the evaluation and management, high severity 689 619 $4K
73130 110 97 $4K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 27 18 $4K
73610 180 172 $4K
73030 162 136 $4K
83036 Hemoglobin; glycosylated (A1C) 343 332 $4K
80076 254 238 $3K
87807 274 249 $3K
82803 142 113 $3K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 203 176 $3K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 437 396 $2K
85610 704 606 $2K
97001 71 52 $2K
80320 153 126 $2K
85379 224 209 $2K
72100 79 66 $2K
71020 133 120 $2K
71010 294 256 $2K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 15 15 $2K
97161 14 14 $1K
82375 120 96 $1K
73630 53 49 $1K
90715 73 66 $1K
96376 90 57 $1K
J1815 Injection, insulin, per 5 units 56 25 $989.82
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 36 31 $896.64
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 852 728 $761.84
80306 52 47 $676.67
74018 25 24 $556.64
85730 128 119 $524.95
87420 30 27 $434.58
J1650 Injection, enoxaparin sodium, 10 mg 44 26 $428.79
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 210 177 $410.15
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 98 89 $407.93
86901 13 12 $350.00
84703 33 30 $348.82
J7050 Infusion, normal saline solution, 250 cc 2,584 1,601 $333.44
80143 14 13 $264.48
82947 55 28 $258.12
36600 148 124 $246.00
80179 13 12 $245.84
J2270 Injection, morphine sulfate, up to 10 mg 647 510 $151.08
83540 28 25 $142.29
83550 28 26 $142.06
82248 32 31 $124.76
84436 15 14 $121.52
81015 48 45 $102.33
85007 46 37 $93.48
84100 14 13 $49.29
J2704 Injection, propofol, 10 mg 31 24 $46.64
86900 13 12 $42.60
J2550 Injection, promethazine hcl, up to 50 mg 132 110 $36.47
J1200 Injection, diphenhydramine hcl, up to 50 mg 16 14 $15.90
J7120 Ringers lactate infusion, up to 1000 cc 320 258 $3.06
J7030 Infusion, normal saline solution , 1000 cc 1,898 1,545 $0.19
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 101 67 $0.16
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 12 12 $0.00
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 659 625 $0.00
A9270 Non-covered item or service 1,797 464 $0.00
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 89 78 $0.00
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 31 28 $0.00
J2250 Injection, midazolam hydrochloride, per 1 mg 20 16 $0.00
J1170 Injection, hydromorphone, up to 4 mg 34 26 $0.00
J3010 Injection, fentanyl citrate, 0.1 mg 25 18 $0.00
J2175 Injection, meperidine hydrochloride, per 100 mg 13 12 $0.00